These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 34998385)
21. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer. Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062 [TBL] [Abstract][Full Text] [Related]
22. BOLA3 is a prognostic-related biomarker and correlated with immune infiltrates in lung adenocarcinoma. Wang XF; Lei W; Liu CM; Yang J; Zhu YH Int Immunopharmacol; 2022 Jun; 107():108652. PubMed ID: 35286914 [TBL] [Abstract][Full Text] [Related]
23. NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma. Yan Y; Gao Z; Han H; Zhao Y; Zhang Y; Ma X; Chen H J Cancer Res Clin Oncol; 2022 Mar; 148(3):565-575. PubMed ID: 34746975 [TBL] [Abstract][Full Text] [Related]
24. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma. Bian J; Xiong W; Yang Z; Li M; Song D; Zhang Y; Liu C Sci Rep; 2024 Jan; 14(1):522. PubMed ID: 38177255 [TBL] [Abstract][Full Text] [Related]
25. DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer. Deng Z; Xiao M; Du D; Luo N; Liu D; Liu T; Lian D; Peng J Onco Targets Ther; 2021; 14():2003-2017. PubMed ID: 33776450 [TBL] [Abstract][Full Text] [Related]
26. DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration. Xu Y; Jiang Q; Liu H; Xiao X; Yang D; Saw PE; Luo B J Immunol Res; 2020; 2020():8835393. PubMed ID: 33490290 [TBL] [Abstract][Full Text] [Related]
27. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer. Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682 [No Abstract] [Full Text] [Related]
28. SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma. Luo L; Su J; Zheng Y; Huang F; Huang R; Luo H J Immunol Res; 2021; 2021():9938397. PubMed ID: 34604392 [TBL] [Abstract][Full Text] [Related]
29. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer. Liang Z; Li X Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760 [TBL] [Abstract][Full Text] [Related]
30. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis. Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K Front Immunol; 2022; 13():903461. PubMed ID: 35663977 [TBL] [Abstract][Full Text] [Related]
31. Overexpression and diagnostic significance of INTS7 in lung adenocarcinoma and its effects on tumor microenvironment. Li X; Yao Y; Qian J; Jin G; Zeng G; Zhao H Int Immunopharmacol; 2021 Dec; 101(Pt B):108346. PubMed ID: 34781123 [TBL] [Abstract][Full Text] [Related]
32. PHD3 as a Prognosis Marker and its Relationship with Immune Infiltration in Lung Adenocarcinoma. Wang L; Zhong Y; Wang G; An H; Gao Q; Ye Y Comb Chem High Throughput Screen; 2022; 25(13):2255-2263. PubMed ID: 35088661 [TBL] [Abstract][Full Text] [Related]
33. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026 [TBL] [Abstract][Full Text] [Related]
34. High Expression of the Component 3a Receptor 1 (C3AR1) Gene in Stomach Adenocarcinomas Infers a Poor Prognosis and High Immune-Infiltration Levels. Yang H; Li L; Liu X; Zhao Y Med Sci Monit; 2021 Feb; 27():e927977. PubMed ID: 33539329 [TBL] [Abstract][Full Text] [Related]
35. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer. Li D; Zhao W; Zhang X; Lv H; Li C; Sun L Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208 [TBL] [Abstract][Full Text] [Related]
36. Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma. Hou Y; Xiang B; Yang Z; Liu J; Xu D; Geng L; Zhan M; Xu Y; Zhang B Int J Immunopathol Pharmacol; 2023; 37():3946320231202748. PubMed ID: 37731383 [No Abstract] [Full Text] [Related]
37. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma. Song S; Deng X; Jiang S; Tian C; Han J; Chai J; Li N; Yan Y; Luo Z J Clin Lab Anal; 2022 Nov; 36(11):e24662. PubMed ID: 36181310 [TBL] [Abstract][Full Text] [Related]
38. [The Expression of RTN1 in Lung Adenocarcinoma and Its Effect on Immune Microenvironment]. Zhu S; Zu L; Xu S Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917 [TBL] [Abstract][Full Text] [Related]
39. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma. Guo Y; Wang ZW; Su WH; Chen J; Wang YL Biomed Res Int; 2020; 2020():4145164. PubMed ID: 32685482 [TBL] [Abstract][Full Text] [Related]
40. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma. Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]